Impaired efferocytosis by monocytes and monocyte-derived macrophages in patients with poorly controlled type 2 diabetes

Figure 4 The monocyte efferocytosis index further decreased in the type 2 diabetes patients with glycosylated hemoglobin levels greater than 11. 0%. A and B: The number and percentage of monocytes, percentage of monocyte subsets; C-E: efferocytosis index of monocytes and monocyte-derived macrophages in healthy controls and in diabetes patients with glycosylated hemoglobin levels lower than 11.0% (D1) or greater than 11.0% (D2). Scale bar: 20 μm. ^aP < 0.05,^cP < 0.001 from paired t test.